Becton, Dickinson and Company (BDX) vs Regeneron Pharmaceuticals, Inc. (REGN)
A side-by-side comparison of Becton, Dickinson and Company and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
BDX
Becton, Dickinson and Company
$166.34HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
REGN
Regeneron Pharmaceuticals, Inc.
$695.18HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — BDX vs REGN
growth of $100 · dividends reinvested · last 25yBDX +932.4%REGN +2401.2%REGN compounded faster
BDX REGN
BDX vs REGN: by the numbers
- •REGN is the larger company ($71.62B vs $60.26B market cap).
- •REGN trades at the lower trailing earnings multiple (16.26 vs 40.23 P/E), one valuation lens rather than an overall verdict.
- •REGN converts more revenue to profit (29.65% vs 5.33% net margin).
- •REGN grew revenue faster over the past five years (10.16% vs 2.52% CAGR).
- •BDX pays the higher dividend yield (2.36% vs 0.55%).
Metrics side by side
Valuation
| Metric | BDX | REGN |
|---|---|---|
| P/E ratio | 40.23 | 16.26 |
| Forward P/E | 12.60 | 14.58 |
| P/S ratio | 2.09 | 4.82 |
| P/B ratio | 1.85 | 2.29 |
| PEG ratio | 2.47 | 3.38 |
| EV / EBITDA | 13.14 | 17.17 |
| FCF yield | 7.05% | 5.78% |
Profitability
| Metric | BDX | REGN |
|---|---|---|
| Gross margin | 46.48% | 84.55% |
| Operating margin | 10.61% | 24.32% |
| Net margin | 5.33% | 29.65% |
| ROE | 4.72% | 14.08% |
| ROIC | 4.73% | 8.51% |
Dividends
| Metric | BDX | REGN |
|---|---|---|
| Dividend yield | 2.36% | 0.55% |
| Payout ratio | 64.09% | 8.45% |
Growth (annualized)
| Metric | BDX | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 10.16% |
| EPS CAGR (5Y) | 16.26% | 5.70% |
| FCF CAGR (5Y) | -5.41% | 15.42% |
| Total return CAGR (5Y) | -2.32% | 3.56% |
Frequently asked
- Which has the lower trailing P/E, BDX or REGN?
- REGN has the lower trailing P/E: BDX trades at 40.23 and REGN at 16.26. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BDX or REGN?
- Over the past five years, REGN grew revenue faster — BDX at a 2.52% CAGR versus REGN at 10.16%.
- Does BDX or REGN pay a bigger dividend?
- BDX yields 2.36% and REGN yields 0.55% based on trailing dividends and the latest price.
- Is BDX or REGN more profitable?
- REGN runs the higher net margin — BDX at 5.33% versus REGN at 29.65%.
- How have BDX and REGN total returns compared?
- Over the past 10 years, BDX delivered 3.35% and REGN delivered 5.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Becton, Dickinson and P/E ratioRegeneron Pharmaceuticals P/E ratioBecton, Dickinson and dividend yieldRegeneron Pharmaceuticals dividend yieldBecton, Dickinson and ROERegeneron Pharmaceuticals ROEBecton, Dickinson and operating marginRegeneron Pharmaceuticals operating marginBecton, Dickinson and revenue growthRegeneron Pharmaceuticals revenue growthBecton, Dickinson and free cash flowRegeneron Pharmaceuticals free cash flow
Becton, Dickinson and & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.